[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer March 30, 2012] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bing Mei Chief Financial Officer March 30, 2012]

[TABLE OFNTENTS TO ANNUAL REPORT ON FORM 10-K FOR YEAR ENDED DECEMBER 31, 2011 Page PART I Item 1. Business 2 Item 1A. Risk Factors 10 Item 1B. Unresolved Staffmments 16 Item 2. Properties 16 Item 3. Legal Proceedings 18 PART II Item 5. 20 Item 7. Managements Discussion and Analysis of Financialnditions and Results] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1.I have reviewed this annual report on Form 10-K ofystar Bio-Pharmaceuticalmpany; 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this annual report on Form 10-K ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer March 30, 2012] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Bing Mei Chief Financial Officer March 30, 2012]

[Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 12, 2012, Skystar Bio-Pharmaceutical Company (the “Company”) received staff determination from the Nasdaq Stock Market (“Exchange”) indicating that since the Company did not hold its annual shareholder meeting by December 31, 2011, the Company was not in compliance with Nasdaq]

[Item 3.01Notice of Delisting or Failure totisfy antinued Listing Rule or Standard; Transfer of Listing. On January 12, 2012,ystar Bio-Pharmaceuticalmpany (thempany) received staff determination from the Nasdaq Stock Market (Exchange) indicating that since thempany did not hold its annual shareholder meeting by December 31, 2011, thempany was not inmpliance with Nasdaq Listing Rule 5620(a) and]